- A monoclonal antibody prevented malaria in people for up to 36 weeks in a Phase 1 clinical trial.
- Such antibodies could have a variety of uses for travelers, military personnel, health care workers, and campaigns to control and eliminate malaria.
Read the full story |
A new study suggests athletes with a history of concussion may show more brain injury from a later concussion, particularly in middle regions of the brain that are more susceptible to damage, when compared to athletes with no history of concussion. The research is published in the August 25, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology. The athletes participated in sports like football, volleyball, and soccer.
Read the full story |
On August 27, 2021, the U.S. Food and Drug Administration approved the MicroTransponder Vivistim Paired VNS System (Vivistim System), a first-of-its-kind, drug-free rehabilitation system intended to treat moderate to severe upper extremity motor deficits associated with chronic ischemic stroke—a stroke caused by a blockage of blood flow to the brain with long-lasting symptoms—using vagus nerve stimulation (VNS).
Read the full story |
The WVU Cancer Institute and WVU Medicine – WVU Hospitals has unveiled LUCAS, a fully mobile unit that will traverse West Virginia providing lung cancer screening in rural areas. It is the first of its kind in the nation.
Read the full story |